In summary, ITGA5, ITGB2, and ITGB5 might synergistically promote SSc through the extracellular matrix turnover, ECM–receptor interaction, focal adhesion, and leukocyte trans-endothelial migration. This evidence concerns the gene ITGB2 and systemic sclerosis.